Quantcast
Last updated on April 18, 2014 at 10:36 EDT
Predicting The Severity Of MRSA

Predicting The Severity Of MRSA

April Flowers for redOrbit.com - Your Universe Online A new technique to predict the toxicity of a MRSA (methicillin-resistant Staphylococcus aureus) infection from its DNA sequence has been developed by a team of researchers led by the...

Latest Staphylococcus aureus Stories

2014-04-16 23:06:57

Officials at Clearstream, LLC, who previously spoke out about MRSA’s prevalence in athletic facilities, are now warning of the infection’s spread to communities. In order to prevent what is now a growing public health threat, Clearstream is advancing the first antimicrobial technology that actively provides long-term protection without the use of harmful poisons. Harrisburg, NC (PRWEB) April 16, 2014 Historically, MRSA infections were relegated to sick patients in hospitals and...

2014-04-15 14:47:01

Penicillin, one of the scientific marvels of the 20th century, is currently losing a lot of battles it once won against bacterial infections. But scientists at the University of South Carolina have just reported a new approach to restoring its combat effectiveness, even against so-called “superbugs.” Bacteria have been chipping away at the power of the penicillin family of drugs since their first wide-scale use as antibiotics in the 1940s. For example, the staph infection, brought...

2014-04-08 12:31:11

WOBURN, Mass. and VEDBAEK, Denmark, April 8, 2014 /PRNewswire/ -- AdvanDx, Inc. today announced it has closed a $12 million financing led by Merck Global Health Innovation Fund (Merck GHI) with participation from existing investors SLS Ventures AB and LD Pensions. The Series B-1 financing will be used to fund the expansion of AdvanDx's molecular diagnostic product offerings, as well as its sales and marketing presence in the U.S. and internationally. "We continue to see increased...

2014-04-08 08:30:41

Vestagen educational campaign advocates for healthcare workers to "Keep the Coat" as an important first line of defense against contaminants ORLANDO, Fla., April 8, 2014 /PRNewswire/ -- To draw attention to the role healthcare worker attire can play in transmitting pathogens, Vestagen Technical Textiles, Inc. today launched a "Keep the Coat" awareness campaign. The effort intends to bring understanding that, with new technological advancements, what care providers wear can actually...

2014-04-03 16:23:53

AUSTIN, Texas, April 3, 2014 /PRNewswire/ -- XBiotech announced today that it acquired the patent estate of Strox Biopharmaceuticals relating to antibody therapies for methicillin resistant staphylococcus aureus (MRSA). XBiotech is developing next generation natural immune therapies to address serious and drug resistant bacterial infections. The in-licensed technology is reportedly intended to expand and strengthen XBiotech's position for its infectious disease product development...

2014-04-03 12:27:08

Lipoglycopeptides Dalvance and Oritavancin Will Find Favorable Uptake as Convenient Outpatient Anti-MRSA Agents, According to Findings from Decision Resources Group BURLINGTON, Mass., April 3, 2014 /PRNewswire/ -- Decision Resources Group finds that following its launch, Cubist's second generation oxazolidinone Sivextro will be highly differentiated from other anti-MRSA (methicillin-resistant Staphylococcus aureus) agents for the treatment of complicated skin and skin structure infections...

Samples of silicone with the various dyes infused
2014-03-26 08:32:06

Oli Usher, University College London Researchers at UCL have developed a new antibacterial material which has potential for cutting hospital-acquired infections. The combination of two simple dyes with nanoscopic particles of gold is deadly to bacteria when activated by light - even under modest indoor lighting. And in a first for this type of substance, it also shows impressive antibacterial properties in total darkness. The research, from by Sacha Noimark and Ivan Parkin (both UCL...

2014-03-24 08:29:42

FAIRFIELD, N.J., March 24, 2014 /PRNewswire/ -- Medimetriks Pharmaceuticals, Inc. announced today a licensing agreement with Ferrer, a privately-held Spanish pharmaceutical company, for the commercialization rights to Ozenoxacin 1% Cream in the United States. Ozenoxacin is a novel, bactericidal non-fluorinated quinolone in development as a topical treatment for impetigo. In 2013, Ferrer successfully completed the first Phase III Clinical Trial of Ozenoxacin in adult and pediatric...

2014-03-19 12:22:44

Clearstream, LLC warns of athletes' increased risk of contracting MRSA due to the bacterium's tendency to target crowded areas with lenient hygiene. Clearstream is advancing antimicrobial technology that actively provides long-term protection without the use of poisons--which no other antimicrobial currently offers. HARRISBURG, N.C., March 19, 2014 /PRNewswire-iReach/ -- Outbreaks of MRSA were once confined to healthcare facilities, but now the bacterium is commonly found in sports...

2014-03-18 12:31:11

WOBURN, Mass., March 18, 2014 /PRNewswire/ -- AdvanDx today announced that it has submitted to the U.S. Food and Drug Administration for 510(k) clearance its new mecA XpressFISH(TM) test for the rapid detection of methicillin-resistant Staphylococcus aureus (MRSA) from S. aureus positive blood cultures. This assay will provide physicians with a new way to rapidly identify MRSA enabling them to implement appropriate treatment for patients with bloodstream infections....


Latest Staphylococcus aureus Reference Libraries

72_eee8f4e550996ac6ae01af15eddb314c
2011-04-26 20:20:41

Staphylococcus aureus is a facultative anaerobic gram-positive coccus, and is the most common cause of staph infections. It is commonly part of the skin flora found in the nose and on skin. Around 20% of the human population is long-term carriers. It gets its golden color due to its carotenoid pigment staphyloxanthin. The pigment acts as a virulence factor with an antioxidant action that allows the microbe to evade death by reactive oxygen species used by the host immune system. Staphylococci...

More Articles (1 articles) »